Quadrature Capital Ltd Sells 9,716 Shares of Chemed Co. (NYSE:CHE)

Quadrature Capital Ltd lessened its holdings in Chemed Co. (NYSE:CHE) by 42.2% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 13,309 shares of the company’s stock after selling 9,716 shares during the period. Quadrature Capital Ltd owned about 0.09% of Chemed worth $8,549,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Rise Advisors LLC purchased a new stake in Chemed during the first quarter valued at approximately $26,000. GAMMA Investing LLC purchased a new stake in shares of Chemed in the 4th quarter worth $37,000. Principal Securities Inc. purchased a new position in Chemed during the fourth quarter valued at $51,000. SRS Capital Advisors Inc. grew its holdings in Chemed by 110.6% during the fourth quarter. SRS Capital Advisors Inc. now owns 99 shares of the company’s stock valued at $58,000 after purchasing an additional 52 shares during the period. Finally, Mather Group LLC. bought a new stake in Chemed during the first quarter valued at about $67,000. Institutional investors own 95.85% of the company’s stock.

Chemed Stock Performance

Shares of Chemed stock traded up $8.30 during trading hours on Friday, hitting $549.27. The company’s stock had a trading volume of 132,672 shares, compared to its average volume of 107,789. Chemed Co. has a 12-month low of $492.84 and a 12-month high of $654.62. The business has a 50 day moving average price of $543.25 and a two-hundred day moving average price of $583.12. The company has a market cap of $8.32 billion, a PE ratio of 29.56, a PEG ratio of 2.23 and a beta of 0.43.

Chemed (NYSE:CHE) last posted its quarterly earnings results on Wednesday, July 24th. The company reported $5.47 EPS for the quarter, missing analysts’ consensus estimates of $5.59 by ($0.12). Chemed had a return on equity of 29.21% and a net margin of 12.88%. The business had revenue of $595.88 million during the quarter, compared to analysts’ expectations of $599.20 million. During the same period in the prior year, the firm posted $4.71 earnings per share. The firm’s revenue for the quarter was up 7.6% on a year-over-year basis. As a group, research analysts anticipate that Chemed Co. will post 21.54 earnings per share for the current year.

Chemed Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 18th. Investors of record on Thursday, May 30th were paid a dividend of $0.40 per share. The ex-dividend date of this dividend was Thursday, May 30th. This represents a $1.60 annualized dividend and a yield of 0.29%. Chemed’s payout ratio is 8.61%.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on CHE. Royal Bank of Canada lowered their price objective on Chemed from $712.00 to $697.00 and set an “outperform” rating on the stock in a research report on Tuesday, May 21st. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, May 4th.

Insider Buying and Selling at Chemed

In other news, CEO Kevin J. Mcnamara sold 1,500 shares of the firm’s stock in a transaction dated Thursday, June 6th. The stock was sold at an average price of $544.17, for a total transaction of $816,255.00. Following the completion of the transaction, the chief executive officer now owns 107,049 shares in the company, valued at $58,252,854.33. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In other news, CEO Kevin J. Mcnamara sold 1,500 shares of the stock in a transaction that occurred on Thursday, June 6th. The stock was sold at an average price of $544.17, for a total transaction of $816,255.00. Following the completion of the transaction, the chief executive officer now directly owns 107,049 shares in the company, valued at approximately $58,252,854.33. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Patrick P. Grace sold 284 shares of the firm’s stock in a transaction on Wednesday, June 12th. The shares were sold at an average price of $540.98, for a total transaction of $153,638.32. Following the completion of the transaction, the director now directly owns 3,270 shares of the company’s stock, valued at $1,769,004.60. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 5,784 shares of company stock worth $3,240,053. Insiders own 3.32% of the company’s stock.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.